Transaction · 0001035422-26-000007

CTT PHARMACEUTICAL HOLDINGS, INC.

CTT PHARMACEUTICAL HOLDINGS, INC., CEO, reported an open-market or private purchase at CTT PHARMACEUTICAL HOLDINGS, INC. involving 2100.000000 shares for an estimated $115.50. Reported holdings after the transaction were 9360756.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PCEO

CTTHCTT PHARMACEUTICAL HOLDINGS, INC.

Filing timeAug 25

Trade dateAug 24, 2026

Filing · SECView on SEC

InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows

Price at filing

—

Pre-filing

1mo ago1w ago1d ago

Returns since

7d30d90d180d1y

CTTH price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards

CTTH since 2026-08-25Filed 10 days ago · 30 days of pre-filing context shaded

Loading…

Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative

Type: Buy
Identifier: 0001035422-26-000007
Transaction date: Aug 24, 2026
Shares: 2.10k sh
Estimated value: $11.5k
Holdings after: 9.36M sh

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M

CEO Buy Direct Ownership

+34score

Filing-only score

+34

Compact filing score computed from stored Form 4 facts. Version v1.

Strong filing signal

This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CEO

Officer YesDirector No10% NoOther No

Footnotes & amended

No footnotes recorded.

Original filing · 0001035422-26-000007

Related transactions

0 other filings

Same reporting owner

Recent company activity

0 recent txs

CTTH